Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin M D'Silva

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Current Rheumatology Reports|April 24, 2021
COVID-19 and Disease-Modifying Anti-rheumatic DrugsKristin M D'Silva, Zachary S Wallace
Current Opinion in Rheumatology|February 24, 2021
COVID-19 and rheumatoid arthritisKristin M D'Silva, Zachary S Wallace
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2025
ReplyJoan T Merrill, Marie-Claude Gaudreau, Kristin M D'Silva
JAAD Case Reports|December 5, 2019
Transient blindness with periorbital erythema and swelling: Manifestations of recurrent systemic lupus erythematosusFarhaan Hafeez, Nicole S Gunasekera, Kristin M D'Silva, et al.
Journal of Thrombosis and Thrombolysis|October 25, 2021
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasiaAbraham Z Cheloff, Andrew B Song, Kristin M D'Silva, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 2, 2020
Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort StudyKristin M D'Silva, Sara Jane Cromer, Elaine W Yu, et al.
Annals of the Rheumatic Diseases|June 18, 2020
Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito <i>et al</i> and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Rachel Wallwork, et al.
Annals of the Rheumatic Diseases|March 11, 2021
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases|January 13, 2021
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic diseaseKristin M D'Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases|June 27, 2020
Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Rachel Wallwork, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Rheumatology Reports|April 24, 2021
COVID-19 and Disease-Modifying Anti-rheumatic DrugsKristin M D'Silva, Zachary S Wallace
Current Opinion in Rheumatology|February 24, 2021
COVID-19 and rheumatoid arthritisKristin M D'Silva, Zachary S Wallace
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2025
ReplyJoan T Merrill, Marie-Claude Gaudreau, Kristin M D'Silva
JAAD Case Reports|December 5, 2019
Transient blindness with periorbital erythema and swelling: Manifestations of recurrent systemic lupus erythematosusFarhaan Hafeez, Nicole S Gunasekera, Kristin M D'Silva, et al.
Journal of Thrombosis and Thrombolysis|October 25, 2021
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasiaAbraham Z Cheloff, Andrew B Song, Kristin M D'Silva, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 2, 2020
Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort StudyKristin M D'Silva, Sara Jane Cromer, Elaine W Yu, et al.
Annals of the Rheumatic Diseases|June 18, 2020
Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito <i>et al</i> and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Rachel Wallwork, et al.
Annals of the Rheumatic Diseases|March 11, 2021
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases|January 13, 2021
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic diseaseKristin M D'Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases|June 27, 2020
Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani <i>et al</i>Kristin M D'Silva, Naomi Serling-Boyd, Rachel Wallwork, et al.
Pageof 5